Can the immune system cure cancer? Dr. Patrick Soon-Shiong discusses a paradigm shift using NK cells to treat tumors without chemotherapy.

Instead of waiting until the disease has progressed, researchers have begun analyzing the effects of using immunotherapy before or after surgery in patients with early-stage lung cancer. The results, ...

The technology allows medics to reach small spots on the lungs that would usually be left to be monitored, speeding up ...

CHICAGO (Reuters) - Adding an experimental mRNA-based vaccine from Moderna Inc and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy ...

Gross and Emanuel recommend a new paradigm for research, one that focuses on improving efficacy and value, as well as ensuring population health impact and generating new knowledge. Specifically, they ...

Some experts argue that overdiagnosis (OD) and overtreatment (OT) of cancer is common and increasingly costly. Others argue that current cure rates are high because of the screening processes ...

Cancer is a heterogeneous disease manifest in many forms. Tumor histopathology can differ significantly among patients and cellular heterogeneity within tumors is common. A primary goal of cancer ...

Please provide your email address to receive an email when new articles are posted on . On Nov. 26, the FDA announced the accelerated approval of larotrectinib as the first small molecule inhibitor ...

PHOENIX, Jan. 10, 2020 /PRNewswire/ -- Paradigm Diagnostics, Inc. announced that Palmetto GBA, the Medicare Administrative Contractor (MAC) for the Molecular Diagnostics MolDX program, has reviewed ...

CHICAGO, June 5 (Reuters) - Adding an experimental mRNA-based vaccine from Moderna Inc (MRNA.O), opens new tab and Merck & Co (MRK.N), opens new tab reduced the risk that the most deadly skin cancer ...